Sign in
4

Changes in Ownership

ANAPTYSBIO, INC Filed Acc 0001209191-19-034870

Chief Medical Officer sold 10,060 shares at an average $73.06 ($734,962)

  • Chief Medical Officer acquired 10,060 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Londei Marco · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-04 Exercise or conversion : show line 1 in the form +10,060 $0.70 $7,042 32,437 D
2019-06-04 Sale : show line 2 in the form −6,009 $72.45 $435,359 26,428 D
2019-06-04 Sale : show line 3 in the form −2,048 $73.43 $150,384 24,380 D
2019-06-04 Sale : show line 4 in the form −2,003 $74.50 $149,219 22,377 D
Open-market sales · 10,060 sh · avg $73.06 · $734,962

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-06-04 Exercise or conversion : show line 5 in the form Employee Stock Option (Right to Buy) −10,060 $0.70 2024-10-27 10,060 0 D
Loading xslF345X03/doc4.xml…